odysseytx.comHealthcare / BioTech & PharmaFounded: 2021Funding to Date: $508.14MM
Odyssey Therapeutics aims to create precision medicines for patients with cancer or inflammatory health issues.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
12/05/2023 | Series C | $117.21MM | $xx.xx | $626.37MM | Ascenta Capital, OrbiMed, SR One, General Catalyst, Foresite Capital, Woodline Partners LP, HBM Healthcare Investments, Colt Ventures, BlackMars Capital GmbH, Creacion Ventures, Fidelity Management & Research Company, T. Rowe Price Associates, Catalio Capital Management, Walleye Capital, Alexandria Venture Investments, Racing Beach Ventures LLC, The Healthcare Innovation Investment Fund LLC, Leerink Partners, Ab Magnitude Ventures, KB Investment, The Global BioAccess Fund | |
Price per Share
$xx.xx
Shares Outstanding
23,442,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Ascenta Capital, OrbiMed, SR One, General Catalyst, Foresite Capital, Woodline Partners LP, HBM Healthcare Investments, Colt Ventures, BlackMars Capital GmbH, Creacion Ventures, Fidelity Management & Research Company, T. Rowe Price Associates, Catalio Capital Management, Walleye Capital, Alexandria Venture Investments, Racing Beach Ventures LLC, The Healthcare Innovation Investment Fund LLC, Leerink Partners, Ab Magnitude Ventures, KB Investment, The Global BioAccess Fund
|
||||||
10/13/2022 | Series B | $168MM | $xx.xx | $616.51MM | General Catalyst, Fidelity, T. Rowe Price Associates, GreatPoint Ventures, Catalio Capital Management, Walleye Capital, Alexandria Venture Investments, The Healthcare Innovation Investment Fund LLC, OrbiMed Advisors, SR One Capital Management, Foresite Capital, Logos Capital, Woodline Partners, HBM Healthcare Investments, Colt Ventures, Creacion Ventures | |
Price per Share
$xx.xx
Shares Outstanding
26,599,787
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
General Catalyst, Fidelity, T. Rowe Price Associates, GreatPoint Ventures, Catalio Capital Management, Walleye Capital, Alexandria Venture Investments, The Healthcare Innovation Investment Fund LLC, OrbiMed Advisors, SR One Capital Management, Foresite Capital, Logos Capital, Woodline Partners, HBM Healthcare Investments, Colt Ventures, Creacion Ventures
|
||||||
12/07/2021 | Series A-2 | $48.1MM | $xx.xx | $390.8MM | OrbiMed Advisors, SR One Capital Management, Woodline Partners, Logos Capital, Foresite Capital, Colt Ventures, HBM Healthcare Investments, Creacion Ventures | |
Price per Share
$xx.xx
Shares Outstanding
7,815,303
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
OrbiMed Advisors, SR One Capital Management, Woodline Partners, Logos Capital, Foresite Capital, Colt Ventures, HBM Healthcare Investments, Creacion Ventures
|
||||||
12/07/2021 | Series A-1 | $44.41MM | $xx.xx | $390.8MM | OrbiMed Advisors, SR One Capital Management, Woodline Partners, Logos Capital, Foresite Capital, Colt Ventures, HBM Healthcare Investments, Creacion Ventures | |
Price per Share
$xx.xx
Shares Outstanding
7,575,753
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
OrbiMed Advisors, SR One Capital Management, Woodline Partners, Logos Capital, Foresite Capital, Colt Ventures, HBM Healthcare Investments, Creacion Ventures
|
||||||
12/07/2021 | Series A | $130.43MM | $xx.xx | $390.8MM | OrbiMed Advisors, SR One Capital Management, Woodline Partners, Logos Capital, Foresite Capital, Colt Ventures, HBM Healthcare Investments, Creacion Ventures | |
Price per Share
$xx.xx
Shares Outstanding
30,039,874
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
OrbiMed Advisors, SR One Capital Management, Woodline Partners, Logos Capital, Foresite Capital, Colt Ventures, HBM Healthcare Investments, Creacion Ventures
|